Healthcare Technology Report August 21, 2024
Roche has effectively acquired LumiraDx’s Point of Care technology, having obtained all necessary antitrust and regulatory clearances. Roche will integrate LumiraDx’s innovative multi-assay point-of-care platform into its global organization, enhancing its diagnostics portfolio. The platform consolidates a wide range of immunoassay and clinical...